Carbonyl reductase, an NADPH-dependent oxidoreductase, catalyzes the reduction of aldehydes and ketones to primary and secondary alcohols, respectively. This enzyme exhibits broad substrate specificity for various endogenous and xenobiotic carbonyl compounds, facilitating the reduction of endogenous prostaglandins, steroids, and other aliphatic aldehydes and ketones. Carbonyl reductases belong to the short-chain dehydrogenases/reductases (SDR) family. Among them, CBR1 plays a crucial role in protecting cells from oxidative stress-induced damage and is extensively studied for its involvement in drug metabolism, particularly in converting the chemotherapeutic agent Doxorubicin into the cardiotoxic metabolite Danurubicin. Additionally, CBR3, a target gene of the Nrf2 transcription factor, is implicated in inflammatory responses[1][2][3].
(8S)-Methyl zearalenone(ZEA analogue 5)是一种选择性羧基还原酶受体1(CBR1)抑制剂,其IC50值为0.21 μM。
CBR1-IN-4(化合物 13p)是一种人 CBR1(carbonyl reductase 1)抑制剂(IC50=0.09 μM),可用于抗癌研究。
Cbr3 Mouse Pre-designed siRNA Set A 包含针对 Cbr3 (Rat) 基因不同区域设计的三对 siRNA,以及阴性对照、FAM 标记阴性对照和阳性对照。
Hydroxy-PP 是一种有效的羰基还原酶 1 (CBR1) 抑制剂(IC50 值为 0.78 μM),同时也有效抑制细胞质酪氨酸激酶 Fyn(IC50 值为 5 nM)。
MonoHER(7-Monohydroxyethylrutoside)是一种可作为心脏保护剂的 CBR1 抑制剂,能以浓度依赖性方式抑制 CBR1 V88 和 CBR1 I88 的活性。
SPR inhibitor 3 (SPRi3) 是一种有效的 sepiapertin 还原酶 (SPR) 抑制剂,在非细胞体系中显示出与人 SPR 的高结合亲和力 (IC50=74 nM),在细胞检测中有效降低生物喋呤水平 (IC50=5.2 μM),并通过降低 BH4 水平减少神经性和炎症性疼痛。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号